|
|
|
| home > white papers > The Importance of ADCC in Assessing Clinically Relevant Differences - Sartorius Stedim BioOutsource Ltd |
|
|
 WHITE PAPERS |
|
|
Sartorius Stedim BioOutsource Ltd
|
|
The Importance of ADCC in Assessing Clinically Relevant Differences
|
|
Biosimilars have caused a revolution in the development of biologic
drugs. The model for biosimilars is a combination of speed to market and
low cost; these are fundamental to any biosimilar development project.
The biosimilars pathway to approval is not always without difficulty,
biosimilars are still relatively new, and as each new applicant is
reviewed we are learning more and more about these molecules.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Quanticate Partners with CluePoints to Offer Data Quality Oversight capabilities
Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints as part of its new Data Quality Oversight service.
More info >> |
|
 |
White Papers |
 |
|
e-tools enhance clinical trial performance
e-novex
In today’s ever-evolving medical business, technological changes require innovation to meet growing market demands and to bring about advances in the industry. One such development currently taking place in the field of clinical research is how e-tools are initiating a boost in the productivity of clinical trials.
More info >> |
|
 |
Industry Events |
 |
10th Annual Summit for Clinical Ops Executives
18-21 February 2019, Hyatt Regency Orlando, Florida
Celebrating its 10th successful year, SCOPE Summit 2019 takes place
February 18-21 in Orlando, FL. Over the course of four stimulating days of
in-depth discussions in 19 different conferences, 3 plenary keynote sessions,
and the ever-popular interactive breakout discussions, the programming focuses
on advances and innovative solutions in all aspects of clinical trial planning,
management and operations, including...
More info >> |
|
|
|
